Education
About Us
Working with TipRanks
Follow Us
GlycoMimetics (GLYC)
NASDAQ:GLYC
Total Valuation
GlycoMimetics has a market cap or net worth of $16.88M. The enterprise value is $5.40M.
Market Cap$16.88M
Enterprise Value$5.40M
Share Statistics
GlycoMimetics has 64,513,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,513,860
Owned by Insiders12.38%
Owned by Institutions0.09%
Financial Efficiency
GlycoMimetics’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is ―.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)-7.54
Revenue Per Employee0.00
Profits Per Employee-9.47B
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GlycoMimetics is 0.00. GlycoMimetics’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio0.00
Income Statement
In the last 12 months, GlycoMimetics had revenue of 0.00 and earned 0.00 in profits. Earnings per share was -0.59.
Revenue0.00
Gross Profit0.00
Operating Income-40.04B
Pretax Income0.00
Net Income0.00
EBITDA-40.04B
Earnings Per Share (EPS)-0.59
Cash Flow
In the last 12 months, operating cash flow was -31.10M and capital expenditures -9.97M, giving a free cash flow of -31.11M billion.
Operating Cash Flow-31.10M
Free Cash Flow-31.11M
Free Cash Flow per Share-0.48
Dividends & Yields
GlycoMimetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change-18.75%
50-Day Moving Average0.24
200-Day Moving Average0.24
Relative Strength Index (RSI)60.55
Average Volume (3m)425.02K
Important Dates
GlycoMimetics upcoming earnings date is Apr 30, 2026, TBA Not Confirmed.
Last Earnings DateMay 1, 2025
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
GlycoMimetics as a current ratio of 1.92, with Debt / Equity ratio of 1.26%
Current Ratio1.92
Quick Ratio1.92
Debt to Market Cap4.16
Net Debt to EBITDA>-0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, GlycoMimetics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
GlycoMimetics EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of >-0.01.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
GlycoMimetics has $10.72M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$10.65M billion.
Cash & Marketable Securities$10.72M
Total Debt$0.00
Net Cash-$10.65M
Net Cash Per Share-$0.17
Tangible Book Value Per Share$82.41
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for GlycoMimetics is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast-0.58%